AS

Ali Shareef Nelliyullathil

Active Director Designated Partner DIN 11656802
DIN 11656802 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Ali Shareef Nelliyullathil

Data last updated:

Ali Shareef Nelliyullathil is a Designated Partner at Cochin Budget Pharmacare Llp (since 2026).

DIN 11656802
Primary Designation Designated Partner
First Appointment 09 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Apr 20262026Active

Board colleagues of Ali Shareef Nelliyullathil

NameDINCompanyDesignation
Anzal Moidu07954418Cochin Budget Pharmacare LlpDesignated Partner
Sadath Nelliyullathil07954409Cochin Budget Pharmacare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Cochin Budget Pharmacare Llp
Premium access

Shareholding and investment profile for Ali Shareef Nelliyullathil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ali Shareef Nelliyullathil

Ali Shareef Nelliyullathil currently holds 1 directorship: Cochin Budget Pharmacare Llp (Designated Partner, since 09 Apr 2026).

Ali Shareef Nelliyullathil was first appointed on 09 Apr 2026 as Designated Partner at Cochin Budget Pharmacare Llp.

The current boards of Ali Shareef Nelliyullathil's companies include Anzal Moidu (Cochin Budget Pharmacare Llp), Sadath Nelliyullathil (Cochin Budget Pharmacare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available